This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

National Institute For Health And Clinical Excellence Recommends Covidien’s BIS Brain Monitoring System

Stocks in this article: COV

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that the UK-based National Institute for Health and Clinical Excellence (NICE) recommends the use of electroencephalography (EEG)-based monitors, specifically the Bispectral Index (BIS™) monitor, as an option for measuring depth of anaesthesia.

The recommendation specifies that the BIS monitor should be used with all patients receiving total intravenous anaesthesia and during any type of general anaesthesia with patients considered at high risk of adverse outcomes. This includes patients at high risk of unintended awareness and patients at high risk of excessively deep anaesthesia. The Covidien BIS Brain Monitoring System helps clinicians assess patient consciousness levels through electrical activity in the brain.

The NICE guidance specifically recommends the BIS system as an option in the care of patients at high risk for unintended awareness (consciousness) or excessively deep anaesthesia levels during surgery. Both can lead to serious short- and long-term health risks, including post-traumatic stress disorder, heart attack, and stroke and in older patients, cognitive dysfunction or “brain fog.”

Patients at high risk for unintended awareness include older patients as well as those with morbid obesity, poor cardiovascular function, presence of two or more chronic diseases, high opiate or alcohol use, intravenous anaesthesia techniques and certain types of surgical procedures.

The recommendation for BIS monitoring as an option in patients receiving total intravenous anaesthesia was made because it is cost effective and because it is not possible to measure anaesthetic concentration in these patients.

“The NICE assessment and recommendations provide clear guidance to anaesthesia professionals regarding the use of depth of anaesthesia monitoring that will greatly improve patient care and safety for individuals at higher risk for adverse reactions to general anaesthesia,” said Scott Kelley, M.D., Chief Medical Officer, Respiratory and Monitoring Solutions, Covidien. “With BIS brain monitoring technology, anaesthetists, in combination with their other standard practices, can accurately determine consciousness and tailor anaesthesia dosing to ensure optimal patient experience and minimize risks.”

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs